Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response

<p dir="ltr">Circulating proteins hold a potential benefit as biomarkers for precision medicine. Previously, we showed that systemic levels of neuropilin-1 (NRP-1) and its associated molecules correlated with poor-prognosis breast cancer. To further identify the role of NRP-1 and its...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Noura Al-Zeheimi (5177066) (author)
مؤلفون آخرون:	Adviti Naik (673163) (author), Charles Saki Bakheit (6632636) (author), Marwa Al Riyami (18618901) (author), Adil Al Ajarrah (18618904) (author), Suaad Al Badi (18618907) (author), Khalid Al Baimani (18618910) (author), Kamran Malik (6632651) (author), Zamzam Al Habsi (18618913) (author), Mansour S. Al Moundhri (18618916) (author), Sirin A. Adham (6632660) (author)
منشور في:	2019
الموضوعات:	Biomedical and clinical sciences Oncology and carcinogenesis neuropilin-1 biomarker breast blood response neoadjuvant SNAI1 PlGF
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response

مواد مشابهة